Thank you to our ACRO 2023 sponsors!

Want to join this list of sponsors for ACRO 2023: The Radiation Oncology Summit?

Email our Industry Relations Manager Lencie Gradishar today!

Corporate Sponsors

Platinum Members:

At Varian, a Siemens Healthineers Company, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 11,000 employees across 70 locations keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

Gold Members:

AstraZeneca  is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

 Myriad Genetics – Discovered the BRCA genes and Developer of Prolaris is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. Fast Company named Myriad among the World’s Most Innovative Companies for 2022.

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. To learn more, visit Novocure.com

Veracyte maker of the Decipher Prostate Genomic Classifier   Veracyte offers the Decipher Prostate Genomic Classifier to help with treatment planning for prostate cancer. Decipher Prostate provides prognostic information to help assess each patient’s individual risk and has been validated in over 70 studies as the most accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival.

ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

Silver Members:

Elekta  As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.

GT Medical Technologies is committed to improving the lives of patients with brain tumors. Extensive clinical expertise informed the design of GammaTile Therapy, which is a surgically targeted radiation therapy (STaRT) that provides immediate, dose-intense treatment at completion of brain tumor resection.

Bronze Members:

Beekley Medical's broad range of single-use disposable products for radiation oncology help you save time, improve clinical efficacy, maximize productivity, and create a more positive patient experience in all areas of treatment planning. 

Blue Earth Diagnostics, Inc   a subsidiary of Bracco Imaging, is a recognized leader in the development and commercialization of novel PET radiopharmaceuticals to inform clinical management for cancer patients. Its portfolio includes a commercial product for recurrent prostate cancer and a robust pipeline of investigational agents. For more information, visit: www.blueearthdiagnostics.com.

At Janssen Biotech, Inc. we have an urgent commitment to make a difference for cancer patients and those living with autoimmune diseases.  Comprised of Janssen Oncology and Janssen Immunology, we deliver transformational biologic medicines to market, and have built a rich legacy of innovative firsts.  For more information, visit www.janssen.com.

Class 1 Exhibitors:

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions, such as the CyberKnife and Radixact systems, designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. Visit & follow us on Accuray,Facebook , LinkedIn  , Twitter & YouTube

Bayer has developed an alpha-particle emitting radioactive therapeutic agent which is approved in more than 50 countries worldwide for the treatment of CRPC and symptomatic bone metastases.  
Bayer has also developed an androgen receptor inhibitor (ARi) for the treatment of  mHSPC & nmCRPC.

Brainlab creates software-driven med tech digitizing, automating and optimizing clinical workflows. Serving physicians, medical professionals and patients in 6000+ hospitals in 121 countries, we’re transforming healthcare to improve the lives of patients everywhere. We employ over 2000 people in 25 locations worldwide. Visit and follow: Brainlab, LinkedIn , Twitter , Facebook  and Instagram.

CDR Systems is a global leader in designing and manufacturing world-class, innovative patient positioning systems and associated consumables to radiation oncology centers of all sizes worldwide. Whether you are a freestanding cancer center or a hospital-based healthcare provider, CDR Systems is able to deliver leading-edge solutions.

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient's motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

Cura Surgical specializes in the development of innovative products made from silver-plated nylon, the company continues to explore new applications and markets for its Silverlon® technology in keeping with its corporate mission to improve clinical outcomes.

Dejavi Innovation

DYN'R US Inc:  SDX is the most effective and precise way to achieve reproducible positioning for breast, lung and other thoracoabdominal lesions. The only voluntary breath-hold system to pair direct lung volume measurement with clear bio-visual feedback, SDX gives providers real-time internal information for the highest accuracy during imaging and treatment.

Fuse Oncology delivers SaaS solutions developed by clinicians for clinicians that break down healthcare workflow & data silos to create a seamless experience for clinicians in radiation oncology. By placing the broader electronic medical record system at the center of the architecture, Fuse eliminates duplicative and inefficient efforts to enable a future where oncology care moves at the speed of patients.

Lantheus:  With more than 60 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Limbus AI develops software for automatic contouring of organs and lymph node volumes, proven to save ROs hours of manual contouring time.  Contours follow consensus guidelines with expert level quality and existing workflows are maintained. Save time with Limbus Contour today!

Since 2004, Mevion Medical Systems has been the leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion was the first company to innovate this new single-room platform and continues to further the science and application of proton therapy. Mevion is headquartered in Littleton, Massachusetts, with a presence in Europe and Asia. For more information, please visit www.mevion.com.

MIM Software Inc. provides indispensable software that standardizes clinical workflows in Radiation Oncology and helps manage and fully leverage the increasing volume and variety of medical imaging required for improved treatment planning. MIM Assistant® provides automation of both routine and complex processes to increase clinical efficiency.

MVision provides GBS™ - powered by AI Guideline Based Segmentation solution for Radiotherapy. We bring best value for clinics and patients: reducing contouring time by 95%, treatment planning in less than one hour and a comprehensive workflow solution for same day treatment. Request a demo: info@mvision.ai or (800) 960-0885.

 Myovant Sciences 

Pfizer Oncology

Radformation's  suite of automation tools utilize intelligent automation to bring efficiency and accuracy to the treatment planning process—automating contouring, treatment planning, plan evaluation, secondary calculations, weekly physics checks, machine QA, and more. Thousands of clinics across the world rely on Radformation's solutions for increased quality, safety, and time-savings in all stages of their workflow. 

Radiology Oncology Systems Adding or replacing a linear accelerator or CT Simulator? ROS (Radiology Oncology Systems) provides refurbished Linear Accelerators, CT Scanners, MRI Systems, PET/CT, and other equipment; as well as equipment removals, purchases, relocations, disposals, installations, storage services, rentals, consultations, valuations, and financing/leasing solutions. Find us at www.oncologysystems.com or email info@oncologysystems.com.

RefleXion transforms radiopharmaceuticals from diagnosing cancer to actively controlling delivery of external-beam radiotherapy by leveraging individual tumor biology. RefleXion’s SCINTIX^TM biology-guided radiotherapy automates targeting and motion management to overcome long-standing barriers preventing definitive radiotherapy for metastatic disease. Alongside radiopharmaceutical company collaborations, RefleXion is co-developing/co-commercializing disease-specific radiotracers for difficult-to-treat late-stage cancers.

Revenue Cycle Coding Strategies is the premier provider of healthcare compliance resources and services. Our key to excellence lies in our team of experts, ranging from experienced coders to clinical radiation therapists to industry leaders. We provide custom solutions for consulting, auditing, coding, and revenue optimization.

TheraPanacea is an innovating health tech company, aiming to standardize cancer treatment planning.  With our AI-powered solution ART-Plan™, we leverage state-of-the-art advancements in artificial intelligence, data science and medical image processing for better radiotherapy experience for patients and medical teams alike.

Vertual provides virtual reality software to help clinicians explain radiation therapy treatment and potential side effects to patients and their families.
With the option to use patient models, generic, or real patient data to show machine movement, location of the tumor, organs at risk and beam position and delivery.

Vision RT   is the inventor of Surface Guided Radiation Therapy (SGRT) and develops solutions using computer vision and AI to help ensure cancer patients’ radiation therapy is delivered safely. With 2,000 + systems installed worldwide, we work to improve the accuracy, efficiency, safety and comfort of radiation therapy.

Class 2 Exhibitors:

TeamBest Global has been proudly developing, manufacturing, and delivering reliable medical equipment and supplies for more than 40 years. TeamBest Global now encompasses a family of trusted companies and organizations with a proven track record of innovation, quality and service in external beam radiation therapy, brachytherapy and vascular brachytherapy solutions.

Since 1984, Bionix has provided the radiation therapy community with innovative and quality solutions. We are dedicated to collaborating with clinicians to create novel approaches for current challenges in radiation oncology, and we strive for elegant, simple and effective solutions with patient outcome in mind.

KARL STORZ provides advanced diagnostic and surgical imaging, integration, and instrumentation for enterprise-wide care, including radiation oncology. The TELE PACK+ compact video system combines everything needed for endoscopic diagnosis and treatment, image capture, and networkability. Pair it with our HD endoscope for enhanced detection and differentiation of lesions. Visit karlstorznetwork1.com.

ONCOSPARK is a technology-enabled, service driven company specializing in value-based care, clinical optimization, compliance, and relational data. Oncospark supports hospitals, practices, providers including Medical Oncology, Radiation Oncology, and Infusion. Our focus includes: RCM, provider strategies, practice modelling and navigating value-based care through augmented optimization. 

Oncology Practice Solutions (OPS) is dedicated to the operational freedom of physicians.
Through a long-term guiding partnership, we bridge operational excellence and continuous improvement for the practices we steward.  OPS was built for oncology physicians, by the oncology physicians of SERO. Our 40+ years of oncology practice experience has refined in us the most productive methods for operational excellence that can be leveraged for our clients – making them more productive.

Barrigel, by Palette Life Sciences, is an injectable biodegradable rectal spacer that separates the 
prostate from the rectum to protect it during radiation therapy treatment for prostate cancer. A 
groundbreaking spacing technology, it is the first and only hyaluronic acid, visually-guided, 
sculptable spacer for customizable coverage. Learn more at Barrigel.com.

PreludeDx provides a patented molecular test (DCISionRT®) for women diagnosed with DCIS (Ductal Carcinoma in Situ) that predicts a woman’s personal likelihood or risk of developing DCIS recurrence in 10 years and invasive breast cancer in 10 years with or without adjuvant radiation therapy after breast conserving surgery. Visit PreludeDx.com

Radiating Hope is a nonprofit focused on appropriate and necessary treatment and equipment for cancer care. Our mission is to improve cancer care, specifically radiation oncology care, around the globe.

Event Sponsors:

PreludeDx is the leading personalized breast cancer diagnostics company dedicated to improving outcomes for patients diagnosed with DCIS (Ductal Carcinoma in Situ). The company provides patients and physicians with evidence-based tools to improve patient outcomes and reduce the cost to the healthcare system by helping to ensure women are not over or under treated. For women diagnosed with DCIS, PreludeDx provides a patented molecular test (DCISionRT®) that predicts a woman’s personal likelihood or risk of developing DCIS recurrence in 10 years and invasive breast cancer in 10 years with or without adjuvant radiation therapy after breast conserving surgery.
Visit PreludeDx.com

Revenue Cycle Coding Strategiesis the premier provider of healthcare compliance resources and services. Our key to excellence lies in our team of experts, ranging from experienced coders to clinical radiation therapists to industry leaders. We provide custom solutions for consulting, auditing, coding, and revenue optimization.

SEAL Sponsors: